In their study, this circRNA was validated to deactivate miR-338-3p, thus triggering cancer progression and glycolysis by increasing the level of low-density lipoprotein receptor-related protein 6 (LRP6), which acts as a coreceptor of WNT ligands and activates WNT/β-catenin signaling [40]. This evidence concerns the gene LRP6 and cancer.